Veradermics (MANE) Shares Outstanding (2024 - 2026)
Veradermics (MANE) reported Shares Outstanding of $37.3 million for Q1 2026, up 4966.99% on a YoY basis from $736933.0 in Q1 2025, and up 4880.3% quarter-over-quarter from $749760.0 in Q4 2025.
Veradermics (MANE) Shares Outstanding (2024 - 2026) Analysis & Trends
Veradermics has reported Shares Outstanding for 3 years, with the latest figure at $37.3 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding rose 4966.99% year-over-year to $37.3 million; the trailing twelve-month figure through Mar 2026 stood at $37.3 million (up 4966.99% YoY), and the FY2025 full-year result was $749760.0, up 1.74% from the prior year.
- Shares Outstanding for Q1 2026 stood at $37.3 million, up from $749760.0 in the prior quarter.
- The five-year high for Shares Outstanding was $37.3 million in Q1 2026, with the low at $736933.0 in Q4 2024.
- Historically, Shares Outstanding has averaged $9.9 million across 3 years, with a median of $743346.5 in 2024.
- Annual changes were most pronounced in 2025 — Shares Outstanding advanced 1.74% — and 2026, when it surged 4966.99%.
- Veradermics' Shares Outstanding stood at $736933.0 in 2024, then increased by 1.74% to $749760.0 in 2025, then surged by 4880.3% to $37.3 million in 2026.
- The last three Shares Outstanding figures came in at $37.3 million (Q1 2026), $749760.0 (Q4 2025), and $736933.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Veradermics | 2.13 Bn | 2.13 Bn | - | 37.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Dec 31, 2025 | 749,760.00 |
| Mar 31, 2025 | 736,933.00 |
| Mar 31, 2025 | 736,933.00 |
| Mar 31, 2025 | 736,933.00 |
| Mar 31, 2025 | 736,933.00 |